NIH-funded research R01 grant

Understanding how immune cells interact in celiac disease to guide healing

Official title: Longitudinal analysis of T-B cell interactions and clonal dynamics to identify immune programs controlling tissue damage and healing in celiac disease

Funded at University of Chicago · NIH-11465673 · Data updated 2026-11-12

A study from the University of Chicago will follow people with celiac disease to understand how immune cells in the gut contribute to damage or healing when gluten is present or restricted.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 10, 2026
Project endJune 30, 2030
Funding year2026
Award (this year)$819,998
NIH project number1R01DK145044-01A1
Project IDNIH-11465673 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with celiac disease who are on or attempting a gluten-free diet and have variable adherence or persistent symptoms.

Less likely to help

Patients without ongoing gluten exposure or without active mucosal injury may not experience direct benefits.

What this research studies

This project will look at how T cells, B cells, and plasma cells in the small intestine influence tissue damage and healing in people with celiac disease. Researchers will study immune cell patterns over time to identify immune programs that lead to ongoing injury or recovery, in the context of adherence to a gluten-free diet. The study will involve tissue samples, blood testing, and possibly biopsies to map immune cell dynamics and their relationship to symptoms and mucosal healing. By linking cellular interactions to clinical outcomes, the work aims to reveal targets that could improve treatment beyond diet alone.

Why it matters

Potential benefit: If successful, the work could reveal immune pathways that promote healing and guide new therapies or monitoring strategies for celiac disease.

How similar studies have gone: Similar approaches have identified complex immune cell interactions in intestinal diseases, supporting the potential for meaningful insights but the exact programs in CeD are still being defined.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Abadie, Valerie — University of Chicago
  • Study coordinator: Abadie, Valerie

Related research

Other NIH-funded projects on the same topics.

  • NanoDiscs: a new way to calm the immune system in celiac disease

    A new, protein-like particle called NanoDiscs is being developed to deliver safe targets to the immune system in people with celiac disease, with the goal of reducing reactions to gluten.

    NIH research Evoq Therapeutics, INC. · Ann Arbor, United States · NIH-11418898

  • Tissue damage and healing in Celiac Disease

    A broad study at the University of Chicago is exploring why some people with celiac disease keep having symptoms and tissue damage even when they try to follow a gluten-free diet.

    NIH research University of Chicago · Chicago, United States · NIH-11392285

  • Gluten-detection devices and telemedicine to help adults with celiac disease

    This project looks at whether using portable gluten sensors and urine gluten tests together with telemedicine can help adults with celiac disease stick to a gluten-free diet and feel better.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11370961

  • Gluten-sensing tech to help manage celiac disease with telemedicine

    A study tests new gluten-detection tools used with online care to help adults with celiac disease manage their condition.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11370183

  • Role of Transglutaminase 2 in Celiac Disease

    A study from Stanford aims to understand how a specific enzyme, TG2, contributes to celiac disease and to test a potential gut-focused treatment that could one day help people avoid dietary controls.

    NIH research Stanford University · Stanford, United States · NIH-11365566

  • Gluten-specific immune responses in a humanized mouse model of celiac disease

    A study in a special mouse that carries human immune system pieces to understand how gluten triggers celiac disease and to test potential therapies.

    NIH research Yale University · New Haven, United States · NIH-11350112

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.